MarketPulse

RAS-addicted cancers

2 articles
BenzingaBenzinga··Na

Revolution Medicines Raises $2.2B in Upsized Offerings to Fuel R&D Pipeline

Revolution Medicines closes $2.2B concurrent offerings, including equity and convertible notes, to accelerate drug development and commercialization.
RVMDRVMDWclinical developmentpublic offering
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Revolution Medicines Raises $2B in Upsized Stock and Convertible Offerings

Revolution Medicines raises $2.0 billion via 10.56M shares at $142/share and $500M convertible notes for R&D and commercialization.
RVMDRVMDWclinical developmentpublic offering